FDA Approves Balloon Device for Eustachian Tube Dysfunction

Share this content:
FDA Approves Balloon Device for Eustachian Tube Dysfunction
FDA Approves Balloon Device for Eustachian Tube Dysfunction

FRIDAY, Sept. 16, 2016 (HealthDay News) -- A device that uses a small balloon to treat Eustachian tube dysfunction has been approved by the U.S. Food and Drug Administration.

The Aera Eustachian Tube Balloon Dilation System enables doctors to insert a catheter through the nose into the Eustachian tube, where a small balloon is inflated and creates a path for mucus and air. The balloon is then deflated and removed.

In clinical trials, 52 percent of participants given the device had normal Eustachian tube test results six weeks after the procedure, compared with 14 percent who were treated with a conventional nasal spray. The most common side effects included Eustachian tube puncture, minor bleeding, and worsening Eustachian tube dysfunction.

The device shouldn't be used by patients under age 22, among those whose Eustachian tube is always open, or among patients in whom the carotid artery protrudes through a gap in the bone that surrounds the Eustachian tube.

The device is produced by Irvine, Calif.-based Acclarent Inc.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Influenza Vaccine 48 Percent Effective Overall

CDC: Influenza Vaccine 48 Percent Effective Overall

More severe H3N2 strain a factor in reduced coverage

D.C. Zika Tests Were Flawed

D.C. Zika Tests Were Flawed

One of the issues with tests was a mathematical error

Experts Warn of Health Threats From Climate Change

Experts Warn of Health Threats From Climate Change

Additional 250,000 deaths/year projected from heat stress, malnutrition, infectious diseases

is free, fast, and customized just for you!

Already a member?

Sign In Now »